Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Ipsen S.A. ADR (IPSEY)

Ipsen S.A. ADR (IPSEY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
30.7900 +1.4400 (+4.91%) 03/12/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 30.7900 unch (unch) 12:07 ET
Quote Overview for Wed, Mar 12th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
30.7900
Day High
30.7900
Open 30.7900
Previous Close 29.3500 29.3500
Volume 300 300
Avg Vol 710 710
Stochastic %K 65.54% 65.54%
Weighted Alpha +5.00 +5.00
5-Day Change +1.6500 (+5.66%) +1.6500 (+5.66%)
52-Week Range 27.1100 - 34.0600 27.1100 - 34.0600
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 9,839,822
  • Shares Outstanding, K 335,258
  • Annual Sales, $ 3,868 M
  • Annual Income, $ 374,300 K
  • EBIT $ 0 M
  • EBITDA $ 1,301 M
  • 60-Month Beta 0.90
  • Price/Sales 2.56
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/25
  • Annual Dividend & Yield 0.21 (0.72%)
  • Most Recent Dividend 0.212 on 05/31/24
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.0600 +9.73%
on 02/27/25
Period Open: 31.2100
30.7900 unch
on 03/12/25
-0.4200 (-1.35%)
since 02/12/25
3-Month
27.2800 +12.87%
on 12/20/24
Period Open: 28.6500
32.2500 -4.53%
on 01/16/25
+2.1400 (+7.47%)
since 12/12/24
52-Week
27.1100 +13.57%
on 08/08/24
Period Open: 29.1600
34.0600 -9.60%
on 05/24/24
+1.6300 (+5.59%)
since 03/12/24

Most Recent Stories

More News
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvayâ„¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.300 (-1.64%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.300 (-1.64%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

AZN : 75.57 (+1.79%)
IPSEY : 30.7900 (+4.91%)
CINC : 29.06 (-0.48%)
ALBO : 44.15 (-0.23%)
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc....

IPSEY : 30.7900 (+4.91%)
ALBO : 44.15 (-0.23%)
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

The market is moving higher, and these small companies are helping.

COMP : 8.80 (+3.04%)
$NASX : 17,648.45 (+1.22%)
DCT : 18.99 (unch)
ALBO : 44.15 (-0.23%)
IPSEY : 30.7900 (+4.91%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Regulatory News:

OTC.VN : 0.300 (-1.64%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Regulatory News:

OTC.VN : 0.300 (-1.64%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy

Regulatory News:

OTC.VN : 0.300 (-1.64%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Regulatory News:

OTC.VN : 0.300 (-1.64%)
IPN : 34.71 (-0.54%)
IPSEY : 30.7900 (+4.91%)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Business Summary

Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.

See More

Key Turning Points

3rd Resistance Point 30.7900
2nd Resistance Point 30.7900
1st Resistance Point 30.7900
Last Price 30.7900
1st Support Level 30.7900
2nd Support Level 30.7900
3rd Support Level 30.7900

See More

52-Week High 34.0600
Fibonacci 61.8% 31.4051
Last Price 30.7900
Fibonacci 50% 30.5850
Fibonacci 38.2% 29.7649
52-Week Low 27.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals